ATOS · Atossa Therapeutics, Inc. · Fails to Deliver
$2.47
+0.02 (+0.82%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt as to the Company's ability to continue as a going concern. The accompanying Condensed Consolidated Financial Statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts and classification of liabilities should the Company be unable to continue as a going concern.”View the 10-Q filed Aug 7, 2026
Market Cap
$20.06M
Shares
9.98M
Volume · Oct 6
28.75K
Avg daily vol (3M)
74.18K
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-09 | 275 | $2.52 | $693 |
| 2026-08-31 | 12,270 | $2.58 | $31,657 |
| 2026-08-27 | 946 | $2.65 | $2,507 |
| 2026-08-25 | 4,359 | $2.64 | $11,508 |
| 2026-08-19 | 4,020 | $2.59 | $10,412 |
| 2026-08-18 | 4,718 | $2.79 | $13,163 |
| 2026-08-17 | 1,849 | $2.60 | $4,807 |
| 2026-08-13 | 292 | $2.35 | $686 |
| 2026-08-12 | 13,854 | $2.36 | $32,695 |
| 2026-08-11 | 2,000 | $2.37 | $4,740 |
| 2026-08-10 | 1,876 | $2.36 | $4,427 |
| 2026-08-06 | 7,295 | $2.39 | $17,435 |
| 2026-08-04 | 492 | $2.17 | $1,068 |
| 2026-07-30 | 4,023 | $2.31 | $9,293 |
| 2026-07-27 | 1,135 | $2.30 | $2,611 |
| 2026-07-23 | 1,459 | $2.43 | $3,545 |
| 2026-07-21 | 5,816 | $2.49 | $14,482 |
| 2026-07-16 | 159 | $2.44 | $388 |
| 2026-07-13 | 6,912 | $2.37 | $16,381 |
| 2026-07-09 | 2,302 | $2.45 | $5,640 |
| 2026-07-08 | 5,049 | $2.49 | $12,572 |
| 2026-07-06 | 8,909 | $2.12 | $18,887 |
Showing 1–22 of 22 settlements